The varied distribution and impact of RAS codon and other key DNA alterations across the translocation cyclin D subgroups in multiple myeloma-Reference-Cited by-同舟云学术

The varied distribution and impact of RAS codon and other key DNA alterations across the translocation cyclin D subgroups in multiple myeloma

Published:2017-02-24 Issue:17 Volume:8 Page:27854-27867
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Stein Caleb K.¹,Pawlyn Charlotte²,Chavan Shweta¹,Rasche Leo¹,Weinhold Niels¹,Corken Adam¹,Buros Amy¹,Sonneveld Pieter³,Jackson Graham H.⁴,Landgren Ola⁵,Mughal Tariq⁶⁷,He Jie⁶,Barlogie Bart¹,Bergsagel P. Leif⁸,Davies Faith E.¹,Walker Brian A.¹,Morgan Gareth J.¹

Affiliation:

1. The Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA

2. The Institute of Cancer Research, London, UK

3. Eramus University, Rotterdam, NL

4. Department of Haematology, Newcastle University, Newcastle-upon-Tyne, UK

5. Memorial Sloan Kettering Cancer Center, New York, New York, USA

6. FoundationOne Medicine, Cambridge, Massachusetts, USA

7. Tufts Medical Center, Boston, Massachusetts, USA

8. Mayo Clinic, Scottsdale, Arizona, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes;Nature Genetics;2024-08-19

2. Liquid Biopsies as Non-Invasive Tools for Mutation Profiling in Multiple Myeloma: Application Potential, Challenges, and Opportunities;International Journal of Molecular Sciences;2024-05-10

3. Approach to High-Risk Multiple Myeloma;Hematology/Oncology Clinics of North America;2024-04

4. Identification of mutation gene prognostic biomarker in multiple myeloma through gene panel exome sequencing and transcriptome analysis in Chinese population;Computers in Biology and Medicine;2023-09

5. Perspectives on the Risk-Stratified Treatment of Multiple Myeloma;Blood Cancer Discovery;2022-06-02